- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/4375 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring hetero atom, e.g. quinolizines, naphthyridines, berberine, vincamine
Patent holdings for IPC class A61K 31/4375
Total number of patents in this class: 3884
10-year publication summary
|
223
|
298
|
267
|
270
|
296
|
303
|
323
|
376
|
333
|
118
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Deciphera Pharmaceuticals, LLC | 245 |
72 |
| Novartis AG | 10327 |
58 |
| Incyte Corporation | 1060 |
51 |
| F. Hoffmann-La Roche AG | 7837 |
46 |
| Immunomedics, Inc. | 246 |
44 |
| Merck Sharp & Dohme LLC | 3729 |
43 |
| Bristol-myers Squibb Company | 4811 |
40 |
| Merck Patent GmbH | 5668 |
37 |
| Hoffmann-La Roche Inc. | 3699 |
36 |
| Bayer Pharma AG | 1026 |
36 |
| Boehringer Ingelheim International GmbH | 4509 |
35 |
| Gilead Sciences, Inc. | 2189 |
31 |
| Bayer AG | 3430 |
29 |
| Shenzhen HighTide Biopharmaceutical, Ltd. | 62 |
27 |
| Pfizer Inc. | 3367 |
26 |
| Takeda Pharmaceutical Company Limited | 2718 |
26 |
| Janssen Pharmaceutica N.V. | 3231 |
24 |
| Genentech, Inc. | 4076 |
23 |
| Neurocrine Biosciences, Inc. | 445 |
23 |
| Pliant Therapeutics, Inc. | 65 |
23 |
| Other owners | 3154 |